+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID06750731

Real World Evaluation of Adherence and Symptom Monitoring Using Remote Digital Tools for Vedolizumab Treatment in Inflammatory Bowel Disease

Led by Mercy Medical Center · Updated on 2026-10-09

200

Participants Needed

6

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the use of a remote monitoring digital health system to track medication adherence, clinical outcomes, and healthcare use in patients with inflammatory bowel disease IBD, including Crohns disease, ulcerative colitis, and undetermined IBD type, who are starting treatment with vedolizumab. This observational study aims to compare adherence between intravenous IV and subcutaneous vedolizumab and assess symptom response and time to response using the novel monitoring system. Participants will use the Tappt web-based system, which involves smart labels attached to their vedolizumab medication for scanning with a mobile device at each dose. They will receive daily reminders and be asked to complete symptom surveys weekly for the first 6 weeks and monthly through 22 weeks. Demographic, social determinants of health, and clinical data will be collected at baseline and various points during the study. Alerts for missed doses or symptom worsening will prompt clinical follow-up. During the 22-week study, participants will regularly enter data on adherence, disease activity, quality of life, anxiety, depression, sleep, pain, self-efficacy, and healthcare utilization through electronic forms without requiring office visits. Clinical teams can monitor data in real-time via a secure platform. Primary outcomes include medication adherence measured by medication possession ratio and self-report secondary outcomes include disease activity indices, biomarker levels, healthcare use, and patient-reported outcomes.

CONDITIONS

Brief Title

Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention

Research Team

L

Liyah Courageux, MS

M

Makena Trout, BS

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here